Despite the plausible product roadmap, any organization evaluating MBS products should keep itself informed, and consider existing functionality only. MBS, at this stage, will likely not appeal to companies that need more complex CRM capabilities or must manage customer relationships through diverse lines of business (LOBs).
axapta aos cluster
the other hand, MBS Axapta should be evaluated in less agile and changing medium and large enterprises (up to $250 million in revenues) where the traditional product feature-functions and scalability still play very important part of the selection. Although its MorphX Development Suite can be used to customize application components, such as tables, forms, reports, queries and menus, customers should ensure that the system modifications are preserved during the product upgrade. The product is best